AHL Investment Management’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
SCM
AHL Investment Management's ANGO Position: Q1 2022 in Review
AHL Investment Management sold out of AngioDynamics (ANGO) in Q1 2022, closing a stake of 65 shares — an estimated $2K sold.
AHL Investment Management first reported a position in ANGO in Q4 2021 and held it in 1 quarter. The position peaked at $2K in Q4 2021. 144 funds tracked by Wall St. Rank hold ANGO as of Q1 2022.
- AHL Investment Management reported no remaining AngioDynamics position as of Q1 2022 after selling out during the quarter.
- AHL Investment Management sold 65 AngioDynamics shares in Q1 2022, an estimated $2K.
- AHL Investment Management first reported a position in AngioDynamics in Q4 2021 and held it in 1 quarter.
- AHL Investment Management's AngioDynamics position peaked at $2K in Q4 2021.
- 144 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2022.
Based on AHL Investment Management's 13F filing for Q1 2022, filed 28 Apr 2022.